Preparation and release efficiency of poly (lactic-co-glycolic) acid nanoparticles for drug loaded paclitaxel

IFMBE Proceedings

Volumn 19 IFMBE, Issue , 2008, Pages 514-517

  Ling, You ^a   Huang, Yueshan ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Nanoparticles; Paclitaxel; PLGA; Release Efficiency; TPGS

Indexed keywords

DRUG PRODUCTS; EFFICIENCY; EMULSIFICATION; LIGHT SCATTERING; MORPHOLOGY; NANOPARTICLES; SCANNING ELECTRON MICROSCOPY; SURFACE MORPHOLOGY; TARGETED DRUG DELIVERY; ULTRAVIOLET SPECTROSCOPY;

EMULSION SOLVENT EVAPORATION; ENCAPSULATION EFFICIENCY; PACLITAXEL; PLGA; POLY LACTIC-CO-GLYCOLIC ACID; RELEASE EFFICIENCY; TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATES; TPGS;

CONTROLLED DRUG DELIVERY;

EID: 78049372725     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-540-79039-6_129     Document Type: Conference Paper

References (14)

1. Wani MC, Taylor HL, Wall ME et al. Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem. Soc 1971, 93:2325-2327
2. Thigpen JT. Chemotherapy for advanced ovarian cancer: overview of randomized trials. Semin Oncol 2000, 27: 11-16 (Pubitemid 30643847)
3. Ishitobi M, Shin E, Kikkawa N. Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weakly paclitaxel. Int J Clin Oncol 2001, 6: 55-58 (Pubitemid 32230365)
4. Chang AY, Rubins J,Asbury R et al. Weekly paclitaxel in advanced non-small cell lung cancer. Semin Oncol 2001, 28: 10-13 (Pubitemid 32953986)
5. Gelderblom H, Verweij J, Nooter K. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001, 37: 1590-1598
6. Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulation. Int J Pharm 2002, 235: 179-192
7. F. Tewes, E. Munniera, B. Antoona, et al. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm 2007, 66: 488-492
8. Zhiping Zhang, Sie Huey Lee, Si-Shen Feng. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 2007, 28: 1889-1899 (Pubitemid 46137995)
9. Khin Yin Win, Si-Shen Feng. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26: 2713-2722
10. L. Mu, S.S. Feng. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel. J Con Rel 2002, 80: 129-144
11. Kai-Hong Huang, Zhao-Hua Zhu, Jian-Hua Liu, et al. preparation and release efficiency of polylactic acid nanoparticle. Chin J Cancer 2005, 24: 1023-1026
12. E. K. Park, S. B. Lee, Y. M. Lee. Preparation and characterization of methoxy poly (ethylene glycol)/poly (caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005, 26: 1053-1061
13. Musumeci T., C.A. Ventura, I. Giannone, et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 2006, 325: 172-179
14. L. Mu, S.S. Feng. A novel controlled release formulation for the anticancer drug paclitaxel: PLGA nanoparticles containing vitamin E TPGS. J Con Rel 2003, 86: 33-48